Navigation Links
Brain implant aims to stifle drug highs

What happens if addicts get no high from the drugs they take?

Researchers at Case Western Reserve and Illinois State universities have received a $390,000 National Institute on Drug Abuse grant to help answer the question.

Addiction experts believe a mechanism that robs drugs of their ability to hook users could treat and possibly cure drug abuse and even dependence.

Pedram Mohseni, an associate professor of electrical engineering and computer science at Case Western Reserve, is buildingand will soon start testinga brain implant aimed at sensing changes in the dopamine levels when a rat is given addictive substances and suppressing the reward-related signals associated with a pleasurable high.

"The idea is to build a closed-loop microsystem that senses and identifies changes in the dopamine levels induced by drugs of abuse, then activates a stimulator in real time to suppress the reward-related signals that promote drug-seeking behavior," said Mohseni, the leader of device development for the research project.

Mohseni has a first-generation prototype implant nearly ready and will take the device to Paul A. Garris, a professor of biological sciences at Illinois State, who will lead device testing in anesthetized laboratory rats as early as next month.

Mohseni's system is connected to a chemical microsensor that senses changes in the brain dopamine levels when a highly addictive amphetamine is administered.

The drug hyperactivates phasic dopamine signaling, or transient dopamine concentration spikes, which control brain reward pathways. This can lead to altered synaptic signaling and in turn overvaluation of cues predicting drug availability, leading to drug reinforcement, Mohseni said.

A computer circuit in the microsystem will use algorithms to determine if the drug-induced phasic dopamine signaling exceeds a threshold level set in the absence of drugs. When the threshold is exceeded, the system will then send electrical impulses to a stimulating electrode in the brain. The impulses are designed to inhibit dopamine neurons, silencing the phasic dopamine signaling.

Mohseni and Garris will spend the next two years evaluating and improving the microsystem. They plan to then seek another grant to test the device on rats that are awake and monitor changes in behavior.


Contact: Kevin Mayhood
Case Western Reserve University

Related medicine news :

1. Voices Against Brain Cancer Commends Brain Cancer Patient for Competing in Ironman Competitions
2. Digital PCR technology detects brain-tumor-associated mutation in cerebrospinal fluid
3. Tallahassee Girl Suffering from Chronic Headaches Diagnose with Lemon-sized Congenital Brain Cyst and Has Brain Surgery at Wolfson Children's Hospital in Jacksonville
4. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
5. Local Teen Organizes Charity WALK to Raise Awareness for Incurable Brain Condition
6. Mapping the brain to understand cultural differences
7. Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
8. Inner speech speaks volumes about the brain
9. Brain region implicated in emotional disturbance in dementia patients
10. Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors
11. CogniFit Launches a Specific Brain Training for ADHD
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... 26, 2015 , ... The Catalent Applied Drug Delivery Institute ... integrate dose form selection in early phase drug development. The first of these ... bringing together the UK’s emerging life sciences companies, corporate partners, and investors, at ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/26/2015)... Aliso Viejo, CA (PRWEB) , ... November 26, ... ... X users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. ... custom style options. These classically-influenced trailer titles work with any font, giving users ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
Breaking Medicine Technology: